reiterateUDRfinnhub
JP Morgan Reiterates Underweight Rating on UDR, Inc. (UDR)
Rating Change JP Morgan analysts reiterated a Underweight rating on UDR, Inc. (NYSE:UDR) on August 04, 2026. Market Context UDR, Inc.
Read moreFeatured By
Real-time context
Upgrades, downgrades, initiations, and price-target changes.
Rating Change JP Morgan analysts reiterated a Underweight rating on UDR, Inc. (NYSE:UDR) on August 04, 2026. Market Context UDR, Inc.
Read moreRating Change Citizens analysts downgraded eBay Inc. (NASDAQ:EBAY) from Market Outperform to Market Perform on August 04, 2026. Market Context eBay Inc.
Read moreRating Change JP Morgan analysts reiterated a Overweight rating on Yum! Brands, Inc. (NYSE:YUM) on August 04, 2026.
Read moreRating Change Barclays analysts reiterated a Overweight rating on aTyr Pharma, Inc. (NASDAQ:LIFE) on August 04, 2026. Market Context aTyr Pharma, Inc.
Read moreRating Change Baird analysts reiterated a Outperform rating on aTyr Pharma, Inc. (NASDAQ:LIFE) on August 04, 2026. Market Context aTyr Pharma, Inc.
Read moreRating Change Citizens analysts reiterated a Market Outperform rating on aTyr Pharma, Inc. (NASDAQ:LIFE) on August 04, 2026. Market Context aTyr Pharma, Inc.
Read moreRating Change Citigroup analysts reiterated a Buy rating on aTyr Pharma, Inc. (NASDAQ:LIFE) on August 04, 2026. Market Context aTyr Pharma, Inc.
Read moreRating Change UBS analysts reiterated a Buy rating on Generac Holdings Inc. (NYSE:GNRC) on August 04, 2026. Market Context Generac Holdings Inc.
Read moreRating Change Cantor Fitzgerald analysts reiterated a Overweight rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on August 04, 2026. Market Context Vertex…
Read moreRating Change Canaccord Genuity analysts reiterated a Hold rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on August 04, 2026. Market Context Vertex Pharmaceuticals…
Read moreRating Change TD Cowen analysts reiterated a Buy rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on August 04, 2026. Market Context Vertex Pharmaceuticals Incorporated…
Read moreRating Change Keybanc analysts reiterated a Overweight rating on Welltower Inc. (NYSE:WELL) on August 04, 2026. Market Context Welltower Inc.
Read moreRating Change Oppenheimer analysts reiterated a Outperform rating on Palo Alto Networks, Inc. (NASDAQ:PANW) on August 04, 2026. Market Context Palo Alto Networks, Inc.
Read moreRating Change Argus Research analysts reiterated a Buy rating on KKR & Co. Inc. (NYSE:KKR) on August 04, 2026.
Read moreRating Change JP Morgan analysts reiterated a Neutral rating on The Progressive Corporation (NYSE:PGR) on August 04, 2026. Market Context The Progressive Corporation operates in…
Read moreRating Change Freedom Broker analysts upgraded Exxon Mobil Corporation (NYSE:XOM) from Sell to Hold on August 04, 2026. Market Context Exxon Mobil Corporation operates in the…
Read moreRating Change HC Wainwright & Co. analysts reiterated a Buy rating on FibroBiologics, Inc. Common Stock (NASDAQ:FBLG) on August 04, 2026.
Read moreRating Change Benchmark analysts initiated coverage on Maywood Acquisition Corp. Unit (NASDAQ:MAYAU) with a Buy rating on August 04, 2026. Market Context Maywood Acquisition Corp.
Read moreRating Change HC Wainwright & Co. analysts reiterated a Buy rating on 5E Advanced Materials Inc. (NASDAQ:FEAM) on August 04, 2026.
Read moreRating Change Benchmark analysts initiated coverage on Inflection Point Acquisition Corp. V (NASDAQ:IPEXU) with a Buy rating on August 04, 2026. Market Context Inflection Point…
Read more